{"ticker": {"uuid": "726229d6-82fd-42d7-9403-cb296aebef30", "symbol": "SVA", "name": "Sernova Biotherapeutics Inc", "exchange": "TOR", "country": "CA", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Sernova Biotherapeutics Inc (TSE:SVA) Is Expected To Breakeven In The Near Future", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T10:05:31+00:00", "published_display": "14 Jul 2026 10:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOYnlBeU5Fb05RMTJObDN5ejhuMnp4MldpVTIwQnhQZHMzel95dnZTSXA3VHc3QVNUbUxPaFljSXdCeG5Fb3B6Tkp5bDE4ZHJORGlsYVBWTjdFeUVOa1hvRHE3b3FOdTNlbl9EMzBHbjZkWl9ERVJYTDJSak8zMG9Gd1FodzV4Q0FIMG1RUnhJcHM3bzdjQmFVaHF0MHNObmRGb0R2TkRsLTRMckVPcmdYeVhSN0ZkbkdXV3d4UmxTVDBxcDBq?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Loss-Making Sernova Biotherapeutics Inc (TSE:SVA) Expected To Breakeven In The Medium-Term", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPOUQwTDUyYkJxXzFYMXBjVGNoand2NHlsSEN4V3ctU3M0QmU1dy1aam41M1ZaV1duMmdtNlJOWUYwQkZMenBPQTFDT0pURDlUVHJfTlhTa3k2Q2JoM0k4RXJCSms5eExSZjNxTUdIbFh3VXBjc3dKWUlwbmtyaGxERkVWUkFfcHdRWEpWOENR?oc=5", "source_name": "Market source", "published_at": "2025-08-30T07:00:00+00:00", "published_display": "30 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Sernova Biotherapeutics Inc (TSE:SVA) Is Expected To Breakeven In The Near Future", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T10:05:31+00:00", "published_display": "14 Jul 2026 10:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOYnlBeU5Fb05RMTJObDN5ejhuMnp4MldpVTIwQnhQZHMzel95dnZTSXA3VHc3QVNUbUxPaFljSXdCeG5Fb3B6Tkp5bDE4ZHJORGlsYVBWTjdFeUVOa1hvRHE3b3FOdTNlbl9EMzBHbjZkWl9ERVJYTDJSak8zMG9Gd1FodzV4Q0FIMG1RUnhJcHM3bzdjQmFVaHF0MHNObmRGb0R2TkRsLTRMckVPcmdYeVhSN0ZkbkdXV3d4UmxTVDBxcDBq?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Loss-Making Sernova Biotherapeutics Inc (TSE:SVA) Expected To Breakeven In The Medium-Term", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPOUQwTDUyYkJxXzFYMXBjVGNoand2NHlsSEN4V3ctU3M0QmU1dy1aam41M1ZaV1duMmdtNlJOWUYwQkZMenBPQTFDT0pURDlUVHJfTlhTa3k2Q2JoM0k4RXJCSms5eExSZjNxTUdIbFh3VXBjc3dKWUlwbmtyaGxERkVWUkFfcHdRWEpWOENR?oc=5", "source_name": "Market source", "published_at": "2025-08-30T07:00:00+00:00", "published_display": "30 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 75, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.13, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": -13.3, "twelve_week_move": -31.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.890125, "market_dynamics_buy_signal": false, "relative_strength": -28.615686, "fair_value_gap": -61.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 28.2016, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, -13.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 47, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 1}, {"label": "TMX Newsfile", "count": 1}, {"label": "Market source", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, -13.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Sernova Biotherapeutics Inc (TSE:SVA) Is Expected To Breakeven In The Near Future"}], "updated_at": "2026-07-18T03:41:08.561705+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}